Importantly, using a specific PAK4 inhibitor (LCH-7749944) effectively reversed the increased migration and enhanced collagen I adhesion observed in MDA-MB-231 cells following exposure to RBCs from metastatic breast cancer patients. The gene discussed is PAK4; the disease is breast carcinoma.